Zhejiang Xianju Pharmaceutical Co Ltd (002332) — Free Cash Flow Generation Index
Zhejiang Xianju Pharmaceutical Co Ltd (002332) has a Free Cash Flow Generation Index of 0.77x as of September 2025. Free cash flow of CN¥100.04 Million represents 1% of operating cash flow (CN¥130.05 Million). Explore capital reinvestment ratio of Zhejiang Xianju Pharmaceutical Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Zhejiang Xianju Pharmaceutical Co Ltd Free Cash Flow Generation Index (2006–2025)
Historical FCF Generation Index trend for Zhejiang Xianju Pharmaceutical Co Ltd across 20 annual periods. For the full cash flow conversion analysis, see 002332 cash flow metrics.
Annual Free Cash Flow Generation for Zhejiang Xianju Pharmaceutical Co Ltd (2006–2025)
Year-by-year Free Cash Flow Generation Index for Zhejiang Xianju Pharmaceutical Co Ltd. Check how aggressively does Zhejiang Xianju Pharmaceutical Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.16x | CN¥38.40 Million | CN¥247.48 Million | CN¥209.07 Million | ▼ -67.6% |
| 2024 | 0.48x | CN¥191.07 Million | CN¥398.66 Million | CN¥207.59 Million | ▼ -20.9% |
| 2023 | 0.61x | CN¥360.85 Million | CN¥595.48 Million | CN¥234.63 Million | ▲ +13.0% |
| 2022 | 0.54x | CN¥326.74 Million | CN¥609.28 Million | CN¥282.54 Million | ▼ -11.4% |
| 2021 | 0.61x | CN¥409.31 Million | CN¥676.15 Million | CN¥266.84 Million | ▼ -28.8% |
| 2020 | 0.85x | CN¥671.06 Million | CN¥789.23 Million | CN¥118.17 Million | ▲ +71.7% |
| 2019 | 0.50x | CN¥257.46 Million | CN¥519.81 Million | CN¥262.34 Million | ▲ +298.7% |
| 2018 | 0.12x | CN¥24.01 Million | CN¥193.27 Million | CN¥169.26 Million | ▼ -52.9% |
| 2017 | 0.26x | CN¥44.18 Million | CN¥167.47 Million | CN¥123.28 Million | ▼ -30.1% |
| 2016 | 0.38x | CN¥58.80 Million | CN¥155.91 Million | CN¥97.10 Million | ▼ -11.0% |
| 2015 | 0.42x | CN¥84.56 Million | CN¥199.61 Million | CN¥115.05 Million | ▲ +79.7% |
| 2014 | 0.24x | CN¥33.38 Million | CN¥141.64 Million | CN¥108.26 Million | ▲ +111.9% |
| 2013 | -1.98x | CN¥-125.80 Million | CN¥63.46 Million | CN¥189.26 Million | ▲ +75.0% |
| 2012 | -7.91x | CN¥-264.58 Million | CN¥33.43 Million | CN¥298.01 Million | ▼ -823.6% |
| 2011 | -0.86x | CN¥-126.51 Million | CN¥147.63 Million | CN¥274.14 Million | ▼ -243.5% |
| 2010 | 0.60x | CN¥92.71 Million | CN¥155.29 Million | CN¥62.58 Million | ▲ +1.2% |
| 2009 | 0.59x | CN¥61.74 Million | CN¥104.68 Million | CN¥42.94 Million | ▲ +191.5% |
| 2008 | -0.64x | CN¥-23.22 Million | CN¥36.03 Million | CN¥59.25 Million | ▼ -314.6% |
| 2007 | 0.30x | CN¥28.99 Million | CN¥96.53 Million | CN¥67.55 Million | ▼ -3.7% |
| 2006 | 0.31x | CN¥16.54 Million | CN¥53.05 Million | CN¥36.51 Million | — |